These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

389 related articles for article (PubMed ID: 17265049)

  • 21. Both location and age predict survival in ependymoma: a SEER study.
    McGuire CS; Sainani KL; Fisher PG
    Pediatr Blood Cancer; 2009 Jan; 52(1):65-9. PubMed ID: 19006249
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Outcome predictors for intracranial ependymoma radiosurgery.
    Kano H; Niranjan A; Kondziolka D; Flickinger JC; Lunsford LD
    Neurosurgery; 2009 Feb; 64(2):279-87; discussion 287-8. PubMed ID: 19190457
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Intracranial ependymomas in adult patients. Diagnosis and histological prognostic factors].
    Figarella-Branger D; Metellus P; Barrié M; Maues de Paula A; Fernandez C; Polivka M; Vital A; Labrousse F; Vignaud JM; Laquerrière A; Rousselet MC; Lacroix C; Saikali S; Chapon F; Gontier MF; Chrétien F; Babin P; Rigau V; Vandenbos F; Peoc'h M; Kujas M; Chinot O; Gouvernet J; Giorgi R; Guyotat J; Jouvet A
    Neurochirurgie; 2007 Jun; 53(2-3 Pt 1):76-84. PubMed ID: 17445840
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differential expression of neuronal genes defines subtypes of disseminated neuroblastoma with favorable and unfavorable outcome.
    Fischer M; Oberthuer A; Brors B; Kahlert Y; Skowron M; Voth H; Warnat P; Ernestus K; Hero B; Berthold F
    Clin Cancer Res; 2006 Sep; 12(17):5118-28. PubMed ID: 16951229
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Disseminated ependymomas of the central nervous system.
    Rezai AR; Woo HH; Lee M; Cohen H; Zagzag D; Epstein FJ
    J Neurosurg; 1996 Oct; 85(4):618-24. PubMed ID: 8814165
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genetic expression profiles of adult and pediatric ependymomas: molecular pathways, prognostic indicators, and therapeutic targets.
    Nagasawa DT; Trang A; Choy W; Spasic M; Yew A; Zarinkhou G; Garcia HM; Yang I
    Clin Neurol Neurosurg; 2013 Apr; 115(4):388-99. PubMed ID: 23374238
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Human telomere reverse transcriptase expression predicts progression and survival in pediatric intracranial ependymoma.
    Tabori U; Ma J; Carter M; Zielenska M; Rutka J; Bouffet E; Bartels U; Malkin D; Hawkins C
    J Clin Oncol; 2006 Apr; 24(10):1522-8. PubMed ID: 16575002
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The transcription factor evi-1 is overexpressed, promotes proliferation, and is prognostically unfavorable in infratentorial ependymomas.
    Koos B; Bender S; Witt H; Mertsch S; Felsberg J; Beschorner R; Korshunov A; Riesmeier B; Pfister S; Paulus W; Hasselblatt M
    Clin Cancer Res; 2011 Jun; 17(11):3631-7. PubMed ID: 21493867
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Correlation between 6q25.3 deletion status and survival in pediatric intracranial ependymomas.
    Monoranu CM; Huang B; Zangen IL; Rutkowski S; Vince GH; Gerber NU; Puppe B; Roggendorf W
    Cancer Genet Cytogenet; 2008 Apr; 182(1):18-26. PubMed ID: 18328946
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Correlation of p53 and KI-67 expression with grade and subtype of ependymoma.
    Manasa LP; Uppin MS; Sundaram C
    Indian J Pathol Microbiol; 2012; 55(3):308-13. PubMed ID: 23032822
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anaplastic ependymoma in children--increasing incidence?
    Talan-Hranilović J; Lambasa S; Kogler A
    Neurol Croat; 1991; 41(1-2):51-5. PubMed ID: 1810398
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Merlin expression in pediatric anaplastic ependymomas real time PCR study.
    Buccoliero AM; Castiglione F; Rossi Degl'Innocenti D; Sardi I; Genitori L; Taddei GL
    Fetal Pediatr Pathol; 2010; 29(4):245-54. PubMed ID: 20594149
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differential involvement of protein 4.1 family members DAL-1 and NF2 in intracranial and intraspinal ependymomas.
    Singh PK; Gutmann DH; Fuller CE; Newsham IF; Perry A
    Mod Pathol; 2002 May; 15(5):526-31. PubMed ID: 12011257
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic classification of relapsing favorable histology Wilms tumor using cDNA microarray expression profiling and support vector machines.
    Williams RD; Hing SN; Greer BT; Whiteford CC; Wei JS; Natrajan R; Kelsey A; Rogers S; Campbell C; Pritchard-Jones K; Khan J
    Genes Chromosomes Cancer; 2004 Sep; 41(1):65-79. PubMed ID: 15236318
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cyclooxygenase-2 (cox-2) expression and angiogenesis in intracranial ependymomas.
    Onguru O; Kurt B; Gunhan O; Soylemezoglu F
    Clin Neuropathol; 2006; 25(5):216-20. PubMed ID: 17007443
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pediatric ependymoma: biological perspectives.
    Kilday JP; Rahman R; Dyer S; Ridley L; Lowe J; Coyle B; Grundy R
    Mol Cancer Res; 2009 Jun; 7(6):765-86. PubMed ID: 19531565
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Outcome-based profiling of astrocytic tumours identifies prognostic gene expression signatures which link molecular and morphology-based pathology.
    Beetz C; Bergner S; Brodoehl S; Brodhun M; Ewald C; Kalff R; Krüger J; Patt S; Kiehntopf M; Deufel T
    Int J Oncol; 2006 Nov; 29(5):1183-91. PubMed ID: 17016650
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular profiling identifies prognostic subgroups of pediatric glioblastoma and shows increased YB-1 expression in tumors.
    Faury D; Nantel A; Dunn SE; Guiot MC; Haque T; Hauser P; Garami M; Bognár L; Hanzély Z; Liberski PP; Lopez-Aguilar E; Valera ET; Tone LG; Carret AS; Del Maestro RF; Gleave M; Montes JL; Pietsch T; Albrecht S; Jabado N
    J Clin Oncol; 2007 Apr; 25(10):1196-208. PubMed ID: 17401009
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gene expression profiling in uveal melanoma: two regions on 3p related to prognosis.
    van Gils W; Lodder EM; Mensink HW; Kiliç E; Naus NC; Brüggenwirth HT; van Ijcken W; Paridaens D; Luyten GP; de Klein A
    Invest Ophthalmol Vis Sci; 2008 Oct; 49(10):4254-62. PubMed ID: 18552379
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Supratentorial ependymomas: prognostic factors and outcome analysis in a retrospective series of 46 adult patients.
    Metellus P; Figarella-Branger D; Guyotat J; Barrie M; Giorgi R; Jouvet A; Chinot O;
    Cancer; 2008 Jul; 113(1):175-85. PubMed ID: 18470910
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.